SEC Company Response from Imunon, Inc. (IMNN) (CIK 0000749647) (IMNN) — Nov 26, 2019
Imunon, Inc. (IMNN) (CIK 0000749647)
Date: Nov. 26, 2019 · CIK: 0000749647 · Accession: 0001493152-19-018447
AI Filing Summary & Sentiment
File numbers found in text: 333-234603
Show Raw Text
CORRESP
1
filename1.htm
Celsion
Corporation
997
Lenox Drive, Suite 100
Lawrenceville,
NJ 08648
VIA
EDGAR
November
26, 2019
United
States Securities and Exchange Commission
Division
of Corporation Finance
Mail
Stop 4561
100
F Street, N.E.
Washington,
DC 20549
Attention:
Mr. Paul Fischer
Re:
Celsion
Corporation
Acceleration
Request for Registration Statement on Form S-1
File
No. 333-234603
Dear
Mr. Buchmiller:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Celsion Corporation (the “Company”) hereby requests
that the effective date and time of the above-referenced registration statement (the “Registration Statement”)
be accelerated to November 27, 2019 at 4:00 p.m., Eastern Time, or at such later time as the Company or its counsel, Goodwin Procter
LLP, may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange
Commission (the “Commission”). Once the Registration Statement is effective, please orally confirm the event
with our counsel, Goodwin Procter LLP, by calling Sam Zucker at (650) 752-3232. We also respectfully request that a copy of the
written order from the Commission verifying the effective time and date of the Registration Statement be sent to our counsel,
Goodwin Procter LLP, Attention: Sam Zucker, by email to szucker@goodwinlaw.com.
If
you have any questions regarding this request, please contact Sam Zucker of Goodwin Procter LLP at (650) 752-3232.
Sincerely,
CELSION
CORPORATION
/s/
Michael H. Tardugno
Michael
H. Tardugno
Chief
Executive Officer
cc:
Jeffrey W. Church (Celsion Corporation)
Sam Zucker (Goodwin Procter LLP)